If you have been reading about generic semaglutide in Brazil, you have probably seen three words used almost interchangeably: generic, similar, and compounded. They are not interchangeable in law, and the difference affects what you can buy, what the pharmacist can hand you, and how much checking you need to do yourself. This post walks through those categories and shows you how to read the registration number, the label, and the bula so you can verify any product on your own.
Generic, similar, and compounded are not the same thing in Brazil. Here is how to read the registration, the bula, and the price before you buy generic semaglutide.
Why generic semaglutide is showing up now
The reference product, the one registered in Brazil by Novo Nordisk, has been protected by a patent. Under Brazil's Industrial Property Law, Lei 9.279/1996, an invention patent lasts 20 years counted from the filing date. Generic versions can only be sold after that protection ends. The exact expiry date for the semaglutide patent in Brazil should be read directly from the INPI (Instituto Nacional da Propriedade Industrial) record, not from a forum post or a news article, including this one. Pull the official record, note the date, and treat that as the source of truth.
Patent expiry does not mean a generic appears on the shelf the next day. Each manufacturer needs its own Anvisa registration. Anvisa reviews quality, bioequivalence data, and manufacturing standards before approving a product. So the real question is not whether the patent has ended, but which companies have a registered product and when that registration was granted. The Anvisa public medicines database (consulta de medicamentos) shows the current list, so check it by active ingredient, semaglutide, and look at each entry's registration status.
Sigue el nivel estimado de cada dosis y sabe cuándo aplicar.
Verlo en la app